1. Analyst View
2. Global Generic Drugs Market
3. US Generic Drugs Market
3.1 Pharmaceutical Market
3.1.1 Branded Drugs
3.1.2 Generic Drugs
4. Regulatory Environment
4.1 Drug Efficacy Study Implementation (DESI) Program
4.2 Hatch-Waxman Act
4.3 Patent Infringement Litigations
4.4 Para IV & the 180-day Marketing Exclusivity
4.5 FDA Requirements
4.6 Generic Initiative for Value & Efficiency (GIVE)
5. Emerging Market Trends
5.1 Patent Expiries of Key Drugs
5.2 Huge Cost Savings
5.3 Biogenerics
5.4 Contract Manufacturing
5.5 Drugs Packaging
5.6 Drugs Delivery
5.7 Favorable Political Environment
5.8 Ageing Population
6. Growth Inhibitors
6.1 Lawsuits
6.2 Entry Barriers
6.3 Price Erosion and Depleting Margins
6.4 Authorized Generics
7. Competitive Landscape
7.1 Market Share of Key Players
7.2 Profile of Key Players
7.2.1 Teva Pharmaceutical Industries Limited
7.2.2 Watson Pharmaceuticals, Inc.
7.2.3 Mylan Laboratories Inc.
7.2.4 Sandoz Inc.
7.2.5 Pfizer
8. Supporting Databases
8.1 Macroeconomic Indicators
8.2 Population
8.3 Demographics
8.4 Healthcare Expenditure
8.5 Healthcare Infrastructure
8.6 Major Causes of Mortality
